Bader, JM;
Geyer, PE;
Müller, JB;
Strauss, MT;
Koch, M;
Leypoldt, F;
Koertvelyessy, P;
... Mann, M; + view all
(2020)
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease.
Molecular Systems Biology
, 16
(6)
, Article e9356. 10.15252/msb.20199356.
Preview |
Text
msb.20199356.pdf - Published Version Download (2MB) | Preview |
Abstract
Neurodegenerative diseases are a growing burden, and there is an urgent need for better biomarkers for diagnosis, prognosis, and treatment efficacy. Structural and functional brain alterations are reflected in the protein composition of cerebrospinal fluid (CSF). Alzheimer's disease (AD) patients have higher CSF levels of tau, but we lack knowledge of systems-wide changes of CSF protein levels that accompany AD. Here, we present a highly reproducible mass spectrometry (MS)-based proteomics workflow for the in-depth analysis of CSF from minimal sample amounts. From three independent studies (197 individuals), we characterize differences in proteins by AD status (> 1,000 proteins, CV < 20%). Proteins with previous links to neurodegeneration such as tau, SOD1, and PARK7 differed most strongly by AD status, providing strong positive controls for our approach. CSF proteome changes in Alzheimer's disease prove to be widespread and often correlated with tau concentrations. Our unbiased screen also reveals a consistent glycolytic signature across our cohorts and a recent study. Machine learning suggests clinical utility of this proteomic signature.
| Type: | Article |
|---|---|
| Title: | Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.15252/msb.20199356 |
| Publisher version: | http://dx.doi.org/10.15252/msb.20199356 |
| Language: | English |
| Additional information: | © 2020 The Authors. Published under the terms of the CC BY 4.0 license This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| Keywords: | Alzheimer's disease, cerebrospinal fluid, mass spectrometry, neurodegeneration, proteomics |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10100894 |
Archive Staff Only
 |
View Item |
